Containing the Ebola outbreak in the Democratic Republic of Congo requires community cooperation and is “everybody’s business”, the World Health Organization has said.
Tedros Adhanom Ghebreyesus, the organisation’s director general, made the plea on Sunday during a visit to eastern Congo where some residents have protested against stringent medical protocols for handling victims’ bodies.
“We can stop this Ebola and anyone who has it can also recover. But the rule … is this thing is everybody’s business and every citizen should be involved,” Ghebreyesus said at the opening of a treatment centre in Bunia, the capital of Ituri province, which is at the centre of the outbreak.
Protesters have complained restrictions on handling victims’ bodies violate local burial rites, a sentiment that has been linked to at least three attacks against health centres.
There is no vaccine for the Bundibugyo virus, the strain behind the current outbreak, but infected people can recover, according to Ghebreyesus.
He said: “If you come to health facilities when you have symptoms, you can get the support and recover, so the key is to come forward as early as possible and to get the necessary support.”
Five patients had recovered and four were to be discharged on Sunday, after the earlier discharge of the other patient, the WHO chief said.
The organisation has recorded 906 suspected cases and 223 suspected deaths in the DRC. Authorities in neighbouring Uganda have confirmed nine cases and one death.
The number of confirmed cases in the DRC had increased to 282, with 42 deaths, after 19 new positive test results were recorded, according to data distributed by the communications ministry on Sunday.
Fighting between rival armed groups in the mineral-rich Ituri region has complicated relief efforts, prompting Ghebreyesus to call for a ceasefire, saying: “No cause, no conflict, no grievance is worth condemning innocent people to death from a preventable disease.”
Brazilian health authorities said they were monitoring two patients for possible Ebola infection in São Paulo and Rio de Janeiro, although one later tested negative for the virus.
A 37-year-old man from DRC “exhibited symptoms such as fever, meeting the definition of a suspected case” of Ebola, the São Paulo state government said on Saturday. The health department in Rio de Janeiro state meanwhile reported that it had activated safety protocols after a man from Uganda showed “viral symptoms such as cough, chills and diarrhoea”. He later tested negative but remained in isolation until the investigation was completed, Brazilian authorities said.
The DRC outbreak – which the WHO has declared a public health emergency of international concern – is the 17th recorded Ebola epidemic in the country. The disease was first identified in the central African country in 1976 and has an average death rate, across all outbreaks, of 50%.
Health officials and aid workers have complained they lack basic supplies such as masks. Medical aid donated by the European Union reached Ituri last week and the US announced $80m (£60m) in additional aid, raising its total commitment to $112m.
The Africa Centres for Disease Control and Prevention said national incident systems must be activated rapidly and that investments in pandemic preparedness must become permanent.
Jean Kaseya, the organisation’s director general, said in the Financial Times on Sunday that international support was vital and most effective when it aligned with the strategies of African institutions and African governments. “Africa’s response to Ebola must be defined by Africa itself,” he wrote.
The medical charity Médecins Sans Frontières (MSF) warned on Saturday that the disease’s spread was deeply alarming and that never before had so many cases been recorded so soon.
MSF teams were “witnessing a response that has not yet caught up to the rapid spread of the epidemic”, said the organisation’s deputy director, Alan Gonzalez. “The reality today is that nobody knows the true scale and severity of this outbreak. New suspected cases are being reported daily, yet hundreds of samples remain untested.”
